Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viscogliosi Brothers Acquisition Corp (VBAC) is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, or similar business combination with one or more businesses. The company specifically targets the musculoskeletal industry, including orthopedics, spinal health, and related healthcare sectors. In 2023, the company announced a definitive business combination agreement with Full Spine, a medical technology company focused on innovative spinal surgery solutions and the Z-Medical brand. Led by the Viscogliosi brothers, the firm leverages deep industry expertise to identify and scale high-growth healthcare technologies in the orthopedic space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viscogliosi Brothers Acquisition Corp.